EMBER THERAPEUTICS, INC. - NY Contracts & Agreements
22 Contracts & Agreements
- Business Finance (13 contracts)
- Human Resources (1)
- Intellectual Property (3)
- Mergers & Acquisitions (2)
- Uncategorized (3)
- Asset Purchase Agreement with Midwood Distributors Inc. for Dermasilk Brand and assets (Filed With SEC on September 27, 2016)
- First Amendment to Distribution, License, and Supply Agreement with Knight Therapeutics, Inc (Filed With SEC on July 14, 2016)
- Asset Purchase Agreement with Migralex, Inc (Filed With SEC on March 28, 2016)
- Asset Purchase Agreement with Intercytex, Ltd (Filed With SEC on March 21, 2016)
- Agreement and Plan of Merger, dated January 31, 2016, by and among American Home Alliance Corporation, Ember Merger Sub, Inc. and Ember Therapeutics, Inc (Filed With SEC on February 3, 2016)
- Consulting Agreement, dated May 14, 2014, by and between Mariel Therapeutics, Inc. and Joseph Hernandez (Filed With SEC on February 3, 2016)
- Asset Purchase Agreement, dated June 30, 2014, by and among Stryker Corporation, Stryker Biotech L.L.C. and Mariel Therapeutics, Inc (Filed With SEC on February 3, 2016)
- Amendment No. 1 to Asset Purchase Agreement, dated July 18, 2014, by and among Stryker Corporation, Stryker Biotech L.L.C. and Mariel Therapeutics, Inc (Filed With SEC on February 3, 2016)
- Amendment No. 2 to Asset Purchase Agreement, dated August 4, 2014, by and among Stryker Corporation, Stryker Biotech L.L.C. and Mariel Therapeutics, Inc (Filed With SEC on February 3, 2016)
- Second Amended and Restated Secured Promissory Note of Mariel Therapeutics, Inc. and Ember Therapeutics, Inc. in favor of Stryker Biotech L.L.C., dated August 3, 2015 (Filed With SEC on February 3, 2016)
- Agreement and Plan of Merger, dated March 11, 2015, by and among Mariel Therapeutics, Inc., Ember Acquisition Corp. and Ember Therapeutics, Inc (Filed With SEC on February 3, 2016)
- Convertible Promissory Note of Mariel Therapeutics, Inc. in favor of Third Rock Ventures II, L.P., dated March 11, 2015 (Filed With SEC on February 3, 2016)
- Letter agreement, dated January 13, 2016, by and between Third Rock Ventures II, L.P. and Ember Therapeutics, Inc (Filed With SEC on February 3, 2016)
- License Agreement, dated March 21, 2012, by and between Joslin Diabetes Center and Ember Therapeutics, Inc (Filed With SEC on February 3, 2016)
- Loan Agreement, dated August 3, 2015, by and between Knight Therapeutics, Inc. and Ember Therapeutics, Inc (Filed With SEC on February 3, 2016)
- General Security Agreement, dated August 3, 2015, by and among Knight Therapeutics, Inc., Mariel Therapeutics, Inc. and Ember Therapeutics, Inc (Filed With SEC on February 3, 2016)
- Guaranty of Mariel Therapeutics, Inc. in favor of Knight Therapeutics, Inc., dated August 3, 2014 (Filed With SEC on February 3, 2016)
- Intercreditor and Subordination Agreement, dated August 3, 2015, by and among Stryker Biotech L.L.C., Stryker Corporation, Knight Therapeutics, Inc., Ember Therapeutics, Inc. and... (Filed With SEC on February 3, 2016)
- Distribution, License and Supply Agreement, dated August 3, 2015, by and between Knight Therapeutics, Inc. and Ember Therapeutics, Inc (Filed With SEC on February 3, 2016)
- Office Sharing Agreement, dated November 1, 2015, by and between Merriman Capital, Inc. and Mariel Advisors, LLC (Filed With SEC on February 3, 2016)
- Conversion and Registration Rights Agreement with Peter Norman (Filed With SEC on February 3, 2016)
- Indemnity Agreement with Peter Norman (Filed With SEC on February 3, 2016)
